Greater China
Legend axes consumer from latest China TMT fund
Legend Capital has excluded the consumer-facing segment from its latest China technology, media, and telecom (TMT) fund, reflecting a broader sense of uncertainty among local managers regarding the regulatory environment.
Clifford Chance poaches Asia funds partner from Kirkland
Clifford Chance has bolstered its Asia private funds offering with the recruitment of Liyong Xing, formerly a partner at Kirkland & Ellis.
China life sciences research business gets $300m Series C
MegaRobo Technologies, a China-based provider of artificial intelligence (AI) and robotics-enabled research services to the life sciences industry, has raised USD 300m in Series C funding.
Capital Today leads $100m round for China's Hai Robotics
Hai Robotics, a China-based warehouse robot company, has raised an extended Series D round of USD100m led by Capital Today China Group.
GP profile: Future Capital
Chinese venture capital firm Future Capital bases its investments on strong networks and research as well as a fondness for founders who are not afraid to confound accepted wisdom
Crypto: Something for everyone?
Traditional VCs are becoming more active in Asia’s blockchain and web3 space, despite structural and philosophical obstacles to participation. Can they withstand the crypto winter?
Monad targets up to $150m for second China software fund
Monad Ventures, a China-based VC firm specialising in early-stage enterprise software investments, is looking to raise up to USD 150m for its second US dollar-denominated fund.
China edge cloud computing provider raises $38m
Shanghai-based distributed cloud computing company PPIO has raised nearly CNY 250m (USD 37.6m) in Series A funding led by Panlin Capital, China Creation Ventures, Shanghai Zhangjiang Technology Venture Investment, and IMO Ventures.
Circle buys VC-backed Taiwan crypto infrastructure platform
Cybavo, a Taiwan-based crypto technology player that provides platforms for digital asset custody and blockchain application development, has agreed to be acquired by US digital currency specialist Circle for an undisclosed sum.
SPAC backed by Vision Knight founder makes Hong Kong debut
A special purpose acquisition company (SPAC) sponsored by David Wei, founder of Vision Knight Capital, has become the second structure of its kind to list in Hong Kong.
Med-Fine leads Series A for China's Degron Therapeutics
US and China-based biotech player Degron Therapeutics has closed a USD 22m Series A round led by Med-Fine Capital.
Fengshi leads $45m Series D for China cancer diagnosis player
Singlera Genomics, a Shanghai-based cancer diagnostics specialist, has raised an extended Series B round of CNY 300m (USD 45m) led by Fengshi Investment Management.
China's Insilico Medicine gets $60m Series D
Insilico Medicine, a China-based artificial intelligence (AI)-driven drug discovery company, has raised a USD 60 million Series D round.
DCP hits $2.5b first close on second China fund
DCP Capital has already completed five investments from its second China fund, having completed a first close of USD 2.5bn in January.
China machine vision company AlpsenTek raises $30m
Chinese machine vision developer AlpsenTek has raised a CNY 200m (USD 30m) Series A round led by Xunxing Investment, an arm of mobile brand Oppo, and Cowin Capital.
China autonomous driving player Minieye raises $120m
Chinese autonomous driving solutions provider Minieye has raised CNY 800m (USD 120m) in Series D funding across three tranches. The third tranche was led by Cathay Capital.
China secondaries: Liquidity play
Under pressure to generate returns amid a challenging fundraising environment, Chinese GPs are beginning to revise pricing expectations to get traction with continuation funds
Deal focus: Hike supports Song Yao’s second act
Orienspace, a Chinese rocket developer founded by the entrepreneur behind DeePhi Technology, has secured USD 60m in funding from Hike Capital and others to accelerate its launch schedule
Cathay achieves $241m first close on renminbi fund
Cathay Capital Private Equity has reached a first close of CNY 1.6bn (USD 241m) on its second renminbi-denominated growth fund.
Vision Fund, GGV back China blockchain infrastructure player
China-based blockchain infrastructure developer InfStones has received USD 66m in funding led by SoftBank Vision Fund 2 and GGV Capital. Ince Capital, 10T Fund, SNZ Holding, and A&T Capital also participated.
Hong Kong's Saltagen targets $120m for biotech fund
Saltagen Ventures, a Hong Kong-based venture capital firm led by Canada’s trade representative to the Asia Pacific Economic Cooperation (APEC) forum, is looking to raise USD 120m for a global biotech fund.
Sequoia leads Series A extension for China's ProfoundBio
Sequoia Capital China has led a USD 70m extended Series A round for ProfoundBio, a Chinese drug developer with two cancer treatments entering phase-one clinical trials.
Boyu, Confitop lead pre-IPO round for China pet food player
Shandong Seek Pet Products, a China-based pet food manufacturer, has raised nearly CNY 500m (USD 75m) in pre-IPO funding led by Boyu Capital and Confitop Capital.
China chip developer Hongjun raises $120m
Chinese chip developer Hongjun Microelectronics has raised CNY 800m (USD 120m) in angel and pre-Series A rounds led by Walden International, GL Ventures, and CDH Venture and Growth Capital.